Texas Medical Center (TMC) has announced a strategic partnership with Enterprise Ireland which aims to provide gateway opportunities for Irish companies, entrepreneurs, researchers, clinicians, and industry partners to collaborate with Texas Medical Center, the world’s largest medical city, to solve global health challenges.
The partnership is designed to bolster collaboration and improvement of patient health and care experience through innovative medical devices, digital health solutions, and therapeutics. Research collaboration will focus on identifying opportunities for clinical research and clinical trial activities.
TMC’s BioBridge programme facilitates the exchange of ideas and research at a global scale to better the patient experience and provide groundbreaking solutions for complex health care problems. The TMC I Ireland BioBridge is TMC’s fourth international partnership. Other global partners include Australia, Denmark and the United Kingdom. Over 80% of TMC Innovation’s current HealthTech Accelerator cohort are composed of international companies, showing the reach of TMC’s international partnerships.
Over the past few months, TMC has worked with LifeLet Medical, a start-up company from Galway, that is developing a novel biomimetic leaflet material for heart valve replacements. Lifelet is part of TMC’s HealthTech Accelerator programme and is supported by Enterprise Ireland. High Potential Start-Ups, InVera Medical and Aurigen Medical are also past participants of the Health Tech Accelerator Programme. LifeLet Medical and Aurigen Medical have also been awarded collaborative funding under Irish government’s Disruptive Technologies Innovation Fund administered by Enterprise Ireland.
Welcoming today’s announcement, Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar said, "Years of investment by Government and industry has created a concentrated community of innovation and expertise within Ireland that is breaking new ground and making a major contribution to international healthcare. Today’s announcement by Texas Medical Center and Enterprise Ireland is a very positive development and will drive further integration and opportunities to bring Irish healthcare innovation to the world."
CEO of Enterprise Ireland, Leo Clancy added, "The size, scale and reputation of Texas Medical Center brings new opportunities for Irish companies to innovate and scale and enter the US market. I am delighted to officially launch this partnership with TMC. Enterprise Ireland places a strong focus on driving innovation in the medtech industry and facilitating successful partnerships between Irish companies and influential global healthcare systems."